Upregulated expression of NRF2 in MS brain lesions suggests that the NRF2 pathway is already highly active in distressed cells (200, 201) and it appears that endogenous antioxidant mechanisms are not enough to halt demyelination and axonal degeneration at end stages of disease. Here, NFE2L2 is linked to myeloid sarcoma.